409406007: Bevacizumab (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Angiogenesis inhibitor\Bevacizumab (substance)
\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance)\Bevacizumab (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Antineoplastic agent (substance)\Bevacizumab (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Monoclonal antibody\Bevacizumab (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody\Bevacizumab (substance)

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody\Bevacizumab (substance)

\Biological substance\Protein and/or protein derivative\Protein\Antibody\Monoclonal antibody\Bevacizumab (substance)
\Biological substance\Immunologic substance\Antibody\Monoclonal antibody\Bevacizumab (substance)
\Biological substance\Polypeptide\Protein\Antibody\Monoclonal antibody\Bevacizumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2004. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Bevacizumab (substance)	Is a	agent d'anticorps monoclonal	false	Inferred relationship	Some
Bevacizumab (substance)	Is a	Angiogenesis inhibitor	true	Inferred relationship	Some
Bevacizumab (substance)	Is a	Monoclonal antibody	true	Inferred relationship	Some
Bevacizumab (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Angiogenesis inhibitor (disposition)	true	Inferred relationship	Some
Bevacizumab (substance)	Is a	Antineoplastic agent (substance)	true	Inferred relationship	Some
Bevacizumab (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Vascular endothelial growth factor receptor antagonist (disposition)	true	Inferred relationship	Some
Bevacizumab (substance)	Is a	Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing bevacizumab (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bevacizumab (substance)	Inferred relationship	Some	1
Bevacizumab 25mg/mL injection solution 4mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bevacizumab (substance)	Inferred relationship	Some
Bevacizumab 25mg/mL injection solution 16mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bevacizumab (substance)	Inferred relationship	Some
Product containing bevacizumab in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bevacizumab (substance)	Inferred relationship	Some	1
Product containing precisely bevacizumab 400 milligram/16 milliliter conventional release solution for injection vial	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Bevacizumab (substance)	Inferred relationship	Some	1
Product containing precisely bevacizumab 400 milligram/16 milliliter conventional release solution for injection vial	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Bevacizumab (substance)	Inferred relationship	Some	1
Product containing precisely bevacizumab 100 milligram/4 milliliter conventional release solution for injection vial	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Bevacizumab (substance)	Inferred relationship	Some	1
Product containing precisely bevacizumab 100 milligram/4 milliliter conventional release solution for injection vial	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Bevacizumab (substance)	Inferred relationship	Some	1
Bevacizumab only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bevacizumab (substance)	Inferred relationship	Some	1
Product containing only bevacizumab in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bevacizumab (substance)	Inferred relationship	Some	1
Product containing precisely bevacizumab 25 milligram/1 milliliter conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Bevacizumab (substance)	Inferred relationship	Some	1
Product containing precisely bevacizumab 25 milligram/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Bevacizumab (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2464857019	Bevacizumab (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2471192013	Bevacizumab	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
55881000195117	bevacizumab	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
193131000077112	bevacizumab	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
794791000172111	bévacizumab	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
70971000195115	Bevacizumab	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module